Heidelberg Pharma AG annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Heidelberg Pharma AG Revenue Growth & History (HPHA)
Heidelberg Pharma AG reported €1.5M in revenue for fiscal 2025, a decrease of 78.69% from the previous fiscal year.
View full Heidelberg Pharma AG company overviewHeidelberg Pharma AG annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-11-30 | €1.5M | −€5.4M | −78.69% |
| 2024 | 2024-11-30 | €6.8M | −€3.0M | −30.53% |
| 2023 | 2023-11-30 | €9.9M | −€8.7M | −46.73% |
| 2022 | 2022-11-30 | €18.5M | €16.8M | +957.71% |
| 2021 | 2021-11-30 | €1.8M | −€6.7M | −79.39% |
| 2020 | 2020-11-30 | €8.5M | €1.2M | +16.14% |
| 2019 | 2019-11-30 | €7.3M | €3.6M | +99.18% |
| 2018 | 2018-11-30 | €3.7M | €1.8M | +93.16% |
| 2017 | 2017-11-30 | €1.9M | €540,000 | +39.71% |
| 2016 | 2016-11-30 | €1.4M | −€920,000 | −40.35% |
| 2015 | 2015-11-30 | €2.3M | −€1.3M | −36.67% |
| 2014 | 2014-11-30 | €3.6M | −€9.7M | −72.97% |
| 2013 | 2013-11-30 | €13.3M | −€2.8M | −17.47% |
| 2012 | 2012-11-30 | €16.1M | €6.3M | +63.36% |
| 2011 | 2011-11-30 | €9.9M | €9.9M | — |
| 2010 | 2010-11-30 | €0 | — | — |
Heidelberg Pharma AG quarterly revenue
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-05-31 | €4.3M | €4.2M | +3566.19% |
| Q1 2026 | 2026-02-28 | €3.0M | €1.8M | +138.66% |
| Q4 2025 | 2025-11-30 | €21,440 | — | — |
| Q2 2025 | 2025-05-31 | €118,513 | — | — |
| Q1 2025 | 2025-02-28 | €1.3M | — | — |
Heidelberg Pharma AG revenue growth trends
Over the last five reported fiscal years, revenue declined from €8.5M to €1.5M, a compound annual decline of 29.68%. Heidelberg Pharma AG's latest reported quarter, Q2 2026, generated €4.3M in revenue, an increase of 3566.19% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Heidelberg Pharma AG source filings ↗Community posts
Heidelberg Pharma reports early myeloma responses and selects a development dose
Heidelberg Pharma ($HPHA) presented Phase 1 results for pamlectabart tismanitin, its experimental antibody-drug conjugate for relapsed or refractory multiple myeloma. Among 31 evaluable patients in dose cohorts five through nine, 13 respond ...
